15 Facts About Jay Keasling

Jay D Keasling is a professor of chemical engineering and bioengineering at the University of California, Berkeley.

Jay Keasling is associate laboratory director for biosciences at the Lawrence Berkeley National Laboratory and chief executive officer of the Joint BioEnergy Institute.

Jay Keasling is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering.

Jay Keasling was elected a member of the National Academy of Engineering in 2010 for developing synthetic biology tools to engineer the antimalarial drug artemisinin.

Jay Keasling received his bachelor's degree at the University of Nebraska-Lincoln where he was a member of Delta Tau Delta International Fraternity.

Related searches

Jay Keasling went on to complete his Doctor of Philosophy degree at the University of Michigan in 1991 under the supervision of Bernhard Palsson.

Jay Keasling's laboratory has developed or adopted many of the latest analytical tools to troubleshoot our genetic manipulations.

Jay Keasling's laboratory has applied metabolic chemistry to a number of real-world problems including the production of the antimalarial drug artemisinin and drop-in biofuels.

Jay Keasling has published over 300 papers in peer-reviewed journals and has over 30 issued patents.

Critical element of Jay Keasling's work was the development of genetic tools to aid in the manipulation of microbial metabolism, particularly for low-value products that require high yields from sugar.

Jay Keasling's laboratory developed single-copy plasmids for the expression of complex metabolic pathways, promoter systems that allow regulated control of transcription consistently in all cells of a culture, mRNA stabilization technologies to regulate the stability of mRNA segments, and a protein engineering approach to attach several enzymes of a metabolic pathway onto a synthetic protein scaffold to increase pathway flux.

Jay Keasling's laboratory has engineered microorganisms to produce hydrocarbons with similar properties to the fuels now derived from petroleum.

Recently, Jay Keasling's laboratory demonstrated that a microorganism could be engineered to synthesize and secrete enzymes to depolymerize cellulose and hemicellulose into sugars and to produce a gasoline replacement, a diesel-fuel replacement, or a jet fuel replacement .

Jay Keasling is a founder of Amyris, LS9, and Lygos .

Jay Keasling is originally from Harvard, Nebraska, and is openly gay.